Reising Ethington continues to seek and successfully obtain intellectual property protection for Cerephex products and trade names
While Reising client Cerephex® has been working through the final stages of obtaining FDA clearance to market their revolutionary NeuroPoint® product for the remediation of Fibromyalgia and other brain-related disorders, Reising Ethington continues to seek and successfully obtain intellectual property protection for Cerephex products and trade names. Recently, Reising attorney Eric Jones travelled with Cerephex® […]